You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK – Qiagen said after the close of the market on Thursday that it has acquired the remaining approximately 80 percent of diagnostics developer NeuMoDx Molecular that it did not already own for $248 million in cash.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.
The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.